首页 | 本学科首页   官方微博 | 高级检索  
     

膀胱癌性激素受体表达与复发率的关系
引用本文:魏强,李虹,李世文,杨宇如,邓显昭,唐孝达,姚先莹. 膀胱癌性激素受体表达与复发率的关系[J]. 现代泌尿外科杂志, 1999, 0(2)
作者姓名:魏强  李虹  李世文  杨宇如  邓显昭  唐孝达  姚先莹
作者单位:华西医科大学附属第一医院泌尿外科,华西医科大学附属第一医院泌尿外科,湖北医学院附属第二医院泌尿外科,华西医科大学附属第一医院泌尿外科,华西医科大学附属第一医院泌尿外科,华西医科大学附属第一医院泌尿外科,华西医科大学附属第一医院病理科 成都,610041,成都,610041,成都,610041,成都,610041,成都,610041
摘    要:本文用荧光组织化学法测定了89例膀胱移行细胞癌雌雄激素受体的表达情况,有77例获长期随访,77例中有32例复发,总复发率为41.56%。采用乘积限法计算受体表达阳性各组及阴性组肿瘤复发率并进行比较。结果提示膀胱癌复发率随雌激素受体表达增多有下降趋势,但无统计学显著差异。雄激素受体表达阳性与否亦与肿瘤复发率无关。

关 键 词:膀胱肿瘤    复发  性激素受体

The Relationship Between Hormone Receptors of Bladder Transitional Cell Carcinoma and Recurence Rate
Wei Qiang,Li Hong,Li Shewing,et al. The Relationship Between Hormone Receptors of Bladder Transitional Cell Carcinoma and Recurence Rate[J]. Journal of MOdern Urology, 1999, 0(2)
Authors:Wei Qiang  Li Hong  Li Shewing  et al
Abstract:Estrogen receptor (ER). and androgen receptor(AR) assays were performed with fluorescent histochemical method in 89 cases of bladder carcinoma. 77 cases were followed-up for at least six years. The tumor recurrence occured in 32(41. 56%). Productlimit estimates were used to calculate the recurrence rate. The results show that there are no statistic differnece of recurrence rate between ER positive and negative groups. There are also no statistic difference of recurrence rate between AR positive and negative groups.
Keywords:bladder neoplasm  carcinoma  recurrence  hormone receptor
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号